FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2625822579> ?p ?o ?g. }

• W2625822579 endingPage "109" @default.
• W2625822579 startingPage "98" @default.
• W2625822579 abstract "Mammary tumorigenesis can be modulated by melatonin, which has oncostatic action mediated by multiple mechanisms, including the inhibition of the activity of transcription factors such as NF-κB and modulation of interleukins (ILs) expression. IL-25 is an active cytokine that induces apoptosis in tumor cells due to differential expression of its receptor (IL-17RB). IL-17B competes with IL-25 for binding to IL-17RB in tumor cells, promoting tumorigenesis. This study purpose is to address the possibility of engaging IL-25/IL-17RB signaling to enhance the effect of melatonin on breast cancer cells. Breast cancer cell lines were cultured monolayers and 3D structures and treated with melatonin, IL-25, siIL-17B, each alone or in combination. Cell viability, gene and protein expression of caspase-3, cleaved caspase-3 and VEGF-A were performed by qPCR and immunofluorescence. In addition, an apoptosis membrane array was performed in metastatic cells. Treatments with melatonin and IL-25 significantly reduced tumor cells viability at 1mM and 1ng/mL, respectively, but did not alter cell viability of a non-tumorigenic epithelial cell line (MCF-10A). All treatments, alone and combined, significantly increased cleaved caspase-3 in tumor cells grown as monolayers and 3D structures (p<0.05). Semi-quantitative analysis of apoptosis pathway proteins showed an increase of CYTO-C, DR6, IGFBP-3, IGFBP-5, IGFPB-6, IGF-1, IGF-1R, Livin, P21, P53, TNFRII, XIAP and hTRA proteins and reduction of caspase-3 (p<0.05) after melatonin treatment. All treatments reduced VEGF-A protein expression in tumor cells (p<0.05). Our results suggest therapeutic potential, with oncostatic effectiveness, pro-apoptotic and anti-angiogenic properties for melatonin and IL-25-driven signaling in breast cancer cells." @default.
• W2625822579 created "2017-06-23" @default.
• W2625822579 creator A5013163755 @default.
• W2625822579 creator A5018738783 @default.
• W2625822579 creator A5024074574 @default.
• W2625822579 creator A5025286087 @default.
• W2625822579 creator A5056640148 @default.
• W2625822579 creator A5062454536 @default.
• W2625822579 creator A5067496567 @default.
• W2625822579 creator A5085076471 @default.
• W2625822579 creator A5089565894 @default.
• W2625822579 date "2017-08-01" @default.
• W2625822579 modified "2023-10-03" @default.
• W2625822579 title "Efficacy of melatonin, IL-25 and siIL-17B in tumorigenesis-associated properties of breast cancer cell lines" @default.
• W2625822579 cites W1555678512 @default.
• W2625822579 cites W1560523639 @default.
• W2625822579 cites W1592648411 @default.
• W2625822579 cites W1604242292 @default.
• W2625822579 cites W1663740629 @default.
• W2625822579 cites W1822934902 @default.
• W2625822579 cites W1831545040 @default.
• W2625822579 cites W1923288651 @default.
• W2625822579 cites W1935309503 @default.
• W2625822579 cites W1958132711 @default.
• W2625822579 cites W1963907102 @default.
• W2625822579 cites W1965037168 @default.
• W2625822579 cites W1970846528 @default.
• W2625822579 cites W1974407486 @default.
• W2625822579 cites W1975474276 @default.
• W2625822579 cites W1981986845 @default.
• W2625822579 cites W1993826373 @default.
• W2625822579 cites W1996712171 @default.
• W2625822579 cites W2005764975 @default.
• W2625822579 cites W2020191309 @default.
• W2625822579 cites W2020857952 @default.
• W2625822579 cites W2023121767 @default.
• W2625822579 cites W2025566628 @default.
• W2625822579 cites W2028085265 @default.
• W2625822579 cites W2029712941 @default.
• W2625822579 cites W2032518219 @default.
• W2625822579 cites W2035772307 @default.
• W2625822579 cites W2046526031 @default.
• W2625822579 cites W2047296832 @default.
• W2625822579 cites W2048785398 @default.
• W2625822579 cites W2051224141 @default.
• W2625822579 cites W2053961328 @default.
• W2625822579 cites W2054077890 @default.
• W2625822579 cites W2057088216 @default.
• W2625822579 cites W2061876901 @default.
• W2625822579 cites W2070165054 @default.
• W2625822579 cites W2072155339 @default.
• W2625822579 cites W2078823089 @default.
• W2625822579 cites W2078938507 @default.
• W2625822579 cites W2079895325 @default.
• W2625822579 cites W2080753273 @default.
• W2625822579 cites W2080931388 @default.
• W2625822579 cites W2081513317 @default.
• W2625822579 cites W2085332471 @default.
• W2625822579 cites W2089890867 @default.
• W2625822579 cites W2090740247 @default.
• W2625822579 cites W2101025849 @default.
• W2625822579 cites W2104432827 @default.
• W2625822579 cites W2109447117 @default.
• W2625822579 cites W2114570899 @default.
• W2625822579 cites W2129361250 @default.
• W2625822579 cites W2131278010 @default.
• W2625822579 cites W2136429046 @default.
• W2625822579 cites W2137846138 @default.
• W2625822579 cites W2145569287 @default.
• W2625822579 cites W2148895922 @default.
• W2625822579 cites W2149003918 @default.
• W2625822579 cites W2151820101 @default.
• W2625822579 cites W2154710335 @default.
• W2625822579 cites W2156930225 @default.
• W2625822579 cites W2327018893 @default.
• W2625822579 cites W2340213580 @default.
• W2625822579 cites W2341578759 @default.
• W2625822579 cites W2523639490 @default.
• W2625822579 doi "https://doi.org/10.1016/j.lfs.2017.06.013" @default.
• W2625822579 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28624391" @default.
• W2625822579 hasPublicationYear "2017" @default.
• W2625822579 type Work @default.
• W2625822579 sameAs 2625822579 @default.
• W2625822579 citedByCount "28" @default.
• W2625822579 countsByYear W26258225792018 @default.
• W2625822579 countsByYear W26258225792019 @default.
• W2625822579 countsByYear W26258225792020 @default.
• W2625822579 countsByYear W26258225792021 @default.
• W2625822579 countsByYear W26258225792022 @default.
• W2625822579 countsByYear W26258225792023 @default.
• W2625822579 crossrefType "journal-article" @default.
• W2625822579 hasAuthorship W2625822579A5013163755 @default.
• W2625822579 hasAuthorship W2625822579A5018738783 @default.
• W2625822579 hasAuthorship W2625822579A5024074574 @default.
• W2625822579 hasAuthorship W2625822579A5025286087 @default.
• W2625822579 hasAuthorship W2625822579A5056640148 @default.
• W2625822579 hasAuthorship W2625822579A5062454536 @default.
• W2625822579 hasAuthorship W2625822579A5067496567 @default.

• next